Abbott Laboratories buy Raymond James
Start price
18.07.25
/
50%
€107.36
Target price
18.07.26
€121.29
Performance (%)
-0.45%
Price
24.07.25
€106.88
Summary
This prediction is currently active. Since the start of the prediction for Abbott Laboratories the price has only changed by -0.45%. This prediction currently runs until 18.07.26. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Abbott Laboratories | -0.45% |
| iShares Core DAX® | -0.519% |
| iShares Nasdaq 100 | -0.737% |
| iShares Nikkei 225® | 3.828% |
| iShares S&P 500 | -0.355% |
Comments by Raymond_James for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Raymond James Financial, Inc. from $142.00 to $141.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Raymond_James for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€116.00
17.04.25
17.04.25
€124.96
17.04.26
17.04.26
-7.86%
24.07.25
24.07.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€107.66
14.10.24
14.10.24
€118.31
14.10.25
14.10.25
0.28%
24.07.25
24.07.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.62
25.01.24
25.01.24
€116.71
25.01.25
25.01.25
16.14%
26.01.25
26.01.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€100.30
03.01.24
03.01.24
€113.61
03.01.25
03.01.25
10.35%
04.01.25
04.01.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€88.90
19.10.23
19.10.23
€104.02
19.10.24
19.10.24
23.73%
20.10.24
20.10.24